Working at the interface of material science, chemistry, biology, and biomedical engineering, we aim to promote healthy aging with a materials-centric approach, to innovate the treatments for degenerative diseases. Our research focuses on translational strategies to develop gene therapies for neurological disorders or chronic diseases.

​

** Recruiting a PhD student with a organic synthesis background in small molecules or polymers for the 2026 Spring or 2026 Fall.